{"page_content": "36\n$.25B$.5B$.75B$1.0B$1.25B$1.5B\n2020$1.5B*\n2019$1.4B*\n2018$1.2B*\n$10M$20M$40M$60M$80M\n2020$67M*\n2018**$69M*\nIn 2020, Amgen-donated\nmedicines reached patients in\nlow- and middle-income \ncountries\nValue of medicines provided at no cost to low-income patients in \nthe United States through the Amgen Safety Net FoundationValue of medicines provided at no cost in low- and \nmiddle-income countries through Direct Relief2020 Performance Data\n*   Valued at wholesale acquisition cost.\n** Amgen provided its first donation to Direct Relief in late 2018, followed by a second donation in 2020. During 2019, Direct Relief worked with local teams and government authorities \nto distribute the medicines at no cost to healthcare professionals in designated low- and middle-income countries for patients in need. ACCESS TO \nMEDICINEINTRODUCTIONRESPONSIBLE \nSOURCINGCOMMUNITY \nINVESTMENTAPPENDIXENVIRONMENTAL\nSUSTAINABILITYDIVERSITY, INCLUSION, \nAND BELONGINGGOVERNANCECOVID- 19 \nRESPONSEBUSINESS \nETHICSETHICAL \nRESEARCH", "metadata": {"source": "NASDAQ_AMGN_2020.pdf", "page": 35, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}